Literature DB >> 7686185

Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis.

P M Desmarchelier1, D A Dance, W Chaowagul, Y Suputtamongkol, N J White, T L Pitt.   

Abstract

Patients with melioidosis may present with recurrent infections after clinical resolution of their primary illness. Because there has been no satisfactory typing scheme for Pseudomonas pseudomallei, recrudescence could not be distinguished from reinfection. We determined the strain identity of primary and relapse isolates of P. pseudomallei from 25 patients with culture-proven melioidosis to answer whether secondary infections were due to the initial infecting strain or to the acquisition of a new strain. Fifty-four isolates were compared by the patterns of BamHI restriction digests produced after hybridization with a cDNA copy of Escherichia coli rRNA. Twenty-three patients had primary and relapse isolates with identical or highly similar ribotype patterns. The patterns of isolates from two patients were different; the primary and relapse isolates differed by a single fragment for one, and the other had identical primary and first-relapse isolates while the second-relapse isolate was markedly different. The results indicated that recurrent infection probably resulted from endogenous relapse in most of the melioidosis patients studied, although reinfection from an exogenous source was also possible in two cases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686185      PMCID: PMC265583          DOI: 10.1128/jcm.31.6.1592-1596.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Melioidosis: a reminder.

Authors:  R E Morrison; A S Lamb; D B Craig; W M Johnson
Journal:  Am J Med       Date:  1988-05       Impact factor: 4.965

2.  Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure.

Authors:  E E Mays; E A Ricketts
Journal:  Chest       Date:  1975-08       Impact factor: 9.410

3.  Evoked potentials: computer-automated threshold-tracking procedure using an objective detection criterion.

Authors:  R J Salvi; W Ahroon; S S Saunders; S A Arnold
Journal:  Ear Hear       Date:  1987-06       Impact factor: 3.570

4.  Chronic or latent melioidosis.

Authors:  C W Kingston
Journal:  Med J Aust       Date:  1971-09-18       Impact factor: 7.738

5.  A probability matrix for the identification of gram-negative, aerobic, non-fermentative bacteria that grow on nutrient agar.

Authors:  B Holmes; C A Pinning; C A Dawson
Journal:  J Gen Microbiol       Date:  1986-07

6.  Inversions between ribosomal RNA genes of Escherichia coli.

Authors:  C W Hill; B W Harnish
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

7.  Chronic melioidosis: a case in Sydney.

Authors:  R C Newland
Journal:  Pathology       Date:  1969-04       Impact factor: 5.306

Review 8.  Melioidosis: the tip of the iceberg?

Authors:  D A Dance
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

9.  Comparison of ribotyping with conventional methods for the type identification of Enterobacter cloacae.

Authors:  J Garaizar; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

Review 10.  Melioidosis: review and update.

Authors:  A Leelarasamee; S Bovornkitti
Journal:  Rev Infect Dis       Date:  1989 May-Jun
View more
  9 in total

1.  Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei.

Authors:  Peter Lowe; Catherine Engler; Robert Norton
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 2.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse.

Authors:  Bina Maharjan; Narisara Chantratita; Mongkol Vesaratchavest; Allen Cheng; Vanaporn Wuthiekanun; Wirongrong Chierakul; Wipada Chaowagul; Nicholas P J Day; Sharon J Peacock
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes.

Authors:  A M Egan; D L Gordon
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

5.  RAPD analysis of isolates of Burkholderia pseudomallei from patients with recurrent melioidosis.

Authors:  A Haase; A Melder; H Smith-Vaughan; D Kemp; B Currie
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

6.  Intracellular survival of Burkholderia pseudomallei.

Authors:  A L Jones; T J Beveridge; D E Woods
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

7.  Melioidosis: an emerging infection in Taiwan?

Authors:  P R Hsueh; L J Teng; L N Lee; C J Yu; P C Yang; S W Ho; K T Luh
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

8.  Pseudomonas pseudomallei isolates collected over 25 years from a non-tropical endemic focus show clonality on the basis of ribotyping.

Authors:  B Currie; H Smith-Vaughan; C Golledge; N Buller; K S Sriprakash; D J Kemp
Journal:  Epidemiol Infect       Date:  1994-10       Impact factor: 2.451

9.  Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.

Authors:  Derek S Sarovich; Erin P Price; Alex T Von Schulze; James M Cook; Mark Mayo; Lindsey M Watson; Leisha Richardson; Meagan L Seymour; Apichai Tuanyok; David M Engelthaler; Talima Pearson; Sharon J Peacock; Bart J Currie; Paul Keim; David M Wagner
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.